Is Genetic Testing Indicated in a Pediatric Patient with Unilateral Hearing Loss or Single‐Sided Deafness?
The Laryngoscope · 2023
DOI: 10.1002/lary.30715 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2023. Verfasst von Armine Kocharyan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Carver College of Medicine University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Hearing Loss, Unilateral, Deafness, Cochlear Implantation, Speech Perception. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS.
Abstract (Originalsprache)
Pediatric unilateral hearing loss (UHL), defined as hearing loss in one ear and normal hearing in the contralateral ear, can range in severity from mild to profound, with profound UHL referred to as single-sided deafness (SSD). Unilateral hearing loss can be congenital or acquired. It occurs at an estimated incidence of 0.6–0.7 in 1000 live births in the United States with increasing incidence (2.5%–6%) in school-age children (Centers for Disease Control Early Hearing Detection and Intervention [CDC] Database). There is a growing body of evidence pointing to the detrimental effects of pediatric SSD on speech development, social interactions, and academic performance. For example, it has been shown that children with congenital UHL have delays in prelingual auditory development. SSD during early development of the auditory system can cause underrepresentation of the deaf ear in the auditory cortex, leading to lateralization of auditory development and “aural preference syndrome.” Increased cognitive effort and reliance on monoaural hearing with poor spatial hearing and impaired speech understanding in noise can make cognitively demanding tasks more challenging, affecting attention, executive function, working memory and cognitive performance. Although there is increasing evidence on the predictive importance of etiologic diagnosis in UHL and SSD, the optimal diagnostic pathways that can guide rehabilitative interventions and follow-up remain controversial. Rehabilitation strategies that depend, in part, on etiology are emerging. For example, cochlear implantation may have a questionable outcome for children with SSD due to significant labyrinthine malformation or cochlear nerve deficiency (CND) but may be strongly considered in cases where the contralateral ear is at risk for progressive hearing loss. Some support the use of imaging, and some question its importance over genetic testing; thus, the assessment of these patients tends to be somewhat physician dependent. Nevertheless, identifying the underlying cause is an essential step in the process of appropriate counseling, treatment, and shared decision-making. This article aims to review the pertinent literature on the etiologic workup of UHL or SSD and provide recommendations on whether genetic testing is routinely indicated in this patient population. The diagnosis of underlying etiology may impact clinical management, predictive accuracy, and the outcome of pediatric sensorineural hearing loss (SNHL). Paul et al. conducted a retrospective study looking at various etiologies of UHL in 80 pediatric patients.1 Inner ear malformation was the leading cause of unilateral SNHL (41%), CND was identified in 33%, and cytomegalovirus (CMV) infection in 10% of cases. A genetic cause was identified in only 6% of patients, suggesting a significantly different etiologic profile of unilateral SNHL compared to bilateral SNHL. The authors conclude that magnetic resonance imaging (MRI) should be the gold standard as CND is a commonly observed etiology in UHL. MRI also has high prevalence of detecting associated brain abnormalities when congenital CMV (cCMV) infection is suspected. The second main cause of UHL in this study was cCMV, which can be assessed by polymerase chain reaction (PCR) on urinary, blood or salivary samples within the first 3 weeks of life or on dried blood samples (DBS).1 In contrast to symptomatic patients with cCMV, who tend to have bilateral SNHL, a majority of asymptomatic patients with cCMV-related early-onset SNHL have UHL but develop SNHL in the contralateral ear by age 18.2 A retrospective study from Belgium looking at the etiologic workup of neonatal hearing screening referrals over 20 years in 77 bilateral and 61 unilateral SNHL patients identified etiologic causes in 77.9% and 67.2%, respectively.3 Although a genetic cause was identified in 58.4% of patients with bilateral SNHL, CND and cCMV infection were implicated in most UHL patients. The authors recommended MRI and cCMV testing as initial steps in the workup of this patient population. In UHL patients, however, genetic testing should be considered if physical examination or imaging indicate a possible underlying syndrome.3 A study looking at a large cohort of 1119 patients who underwent comprehensive clinical and genetic testing for hearing loss using targeted genomic enrichment and massively parallel sequencing reported diagnostic rates based on the hearing loss phenotype and ethnicity.4 A genetic diagnosis was most likely in patients reporting a positive family history or when hearing loss was congenital and symmetric. UHL was found to have the lowest yield, with a diagnostic rate of only 1% driven by syndromic physical exam findings. Based on these outcomes, the authors did not support comprehensive genetic testing for UHL in patients with a normal physical exam.4 To determine whether broader testing can improve diagnostic yield, Perry et al. evaluated the results of exome sequencing (ES) in a cohort of pediatric patients that included 60 children with UHL. They reported a diagnostic rate of 18.3%, however after accounting for patients with syndromic features and excluding genetic variants not classified as pathogenic or likely pathogenic, the diagnostic yield drops to ~5%, consistent with other studies. In comparison, the yield of imaging studies was ~53% (28/52).5 As a best practice, a sequential approach is recommended in the evaluation of UHL or SSD. Given the etiologic profile of UHL and SSD, MRI, and cCMV testing (limited in its time of application) are recommended to rule out labyrinthine abnormalities, CND and congenital CMV infection. In cases when MRI is negative or consistent with abnormalities that will warrant further investigation, CT can be used as a complementary imaging modality to detect bony structural abnormalities. Routine and initial use of genetic testing is not recommended if there are no imaging or physical exam findings consistent with syndromic features or a family history of hearing loss. However, a stepwise approach is recommended, and genetic testing should be considered when the most common nongenetic causes (congenital CMV, negative imaging for structural inner ear, or cochlear nerve abnormality) are ruled out as subtle phenotypic manifestations of syndromic hearing loss and incomplete penetrance occur, and some UHL will further progress to bilateral. One cross-sectional (Level 3), two retrospective (Level 4), and two prospective studies (Level 2) were evaluated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Carver College of Medicine University of Iowa, Iowa City, Iowa, USA.
- Molecular Otolaryngology and Renal Research Laboratories, Department of Otolaryngology-Head and Neck Surgery, Roy J. and Lucille A. Carver College of Medicine University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Armine Kocharyan, Richard J H Smith, Marlan R Hansen
Förderung
- NIDCD NIH HHS
Zitieren
APA
Kocharyan, A., Schaefer, A. M., Smith, R. J. H., & Hansen, M. R. (2023). Is Genetic Testing Indicated in a Pediatric Patient with Unilateral Hearing Loss or Single‐Sided Deafness?. The Laryngoscope. https://doi.org/10.1002/lary.30715
Vancouver
Kocharyan A, Schaefer AM, Smith RJH, Hansen MR. Is Genetic Testing Indicated in a Pediatric Patient with Unilateral Hearing Loss or Single‐Sided Deafness?. The Laryngoscope. 2023. doi:10.1002/lary.30715
BibTeX
@article{Kocharyan2023,
author = {Kocharyan, Armine and Schaefer, Amanda M and Smith, Richard J H and Hansen, Marlan R},
title = {Is Genetic Testing Indicated in a Pediatric Patient with Unilateral Hearing Loss or Single‐Sided Deafness?},
journal = {The Laryngoscope},
year = {2023},
doi = {10.1002/lary.30715}
}
EUVIMED